Simvastatin

Routes
Oral (PO)
Half-Life (t½)
PO: 3h
Formula
C25H38O5
Molecular Weight
418.57 g/mol
PubChem CID
54454
Aliases
Zocor

Pharmacological Mechanism

Lactone prodrug of simvastatin acid. Lipophilic — greater CNS penetration than rosuvastatin. CYP3A4 substrate — heavy interaction profile. Peak endogenous cholesterol synthesis occurs nocturnally → evening dosing for short-t½ statins.

Half-Life & Elimination Curve (PO: 3h)

100%50%25%12.5%0%0h0×t½3h1×t½6h2×t½9h3×t½12h4×t½15h5×t½0×t½ (0h): 100% remaining (~5.96 µg/L)1×t½ (3h): 50% remaining (~2.98 µg/L)2×t½ (6h): 25% remaining (~1.49 µg/L)3×t½ (9h): 12.5% remaining (~0.746 µg/L)4×t½ (12h): 6.3% remaining (~0.373 µg/L)5×t½ (15h): 3.1% remaining (~0.186 µg/L)
Elimination (PO)
  • 0×t½0h100% (5.96 µg/L)
  • 1×t½3h50% (2.98 µg/L)
  • 2×t½6h25% (1.49 µg/L)
  • 3×t½9h12.5% (0.746 µg/L)
  • 4×t½12h6.3% (0.373 µg/L)
  • 5×t½15h3.1% (0.186 µg/L)
Elimination t½3h (PO)
Rate Constant (ke)0.231 h⁻¹
Est. Peak (Cmax)5.96 µg/L
Clearance (CL)32.3 L/h
97% Washout (5×t½)15h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Chemical Structure & Identifiers

References